Thomas Pranikoff

Dr. Thomas Pranikoff

orcid

Research Focus & Metrics

Representative Publications

View All Publications
1 April 2016 in Methods
Verified
Journal Article
Closed access
HSHooman Sadriardekani
Hooman Sadriardekani
TPThomas Pranikoff
Thomas Pranikoff
SKStanley Kogan
Stanley Kogan
JSJoseph Sirintrapun
Joseph Sirintrapun
KCKathryn Crowell
Kathryn Crowell
AAAnthony Atala
Anthony Atala

15 October 2026 in Genes
Verified
Journal Article
Open access
PDF file
IMIsabella Mullally
Isabella Mullally
ESEugene Smith
Eugene Smith
PBPeter Bedocs
Peter Bedocs
TPThomas Pranikoff
Thomas Pranikoff
LBLeslie G. Biesecker
Leslie G. Biesecker
ABAlakesh Bera
Alakesh Bera
Malignant Hyperthermia Susceptibility (MHS) is most commonly caused by pathogenic variants in the RYR1 gene. The proliferation of RYR1 Variants of Uncertain Significance (VUS) on diagnostic genetic panels poses a significant clinical challenge, often leading to unnecessarily complex clinical concerns. We report the case of a 27-year-old African American female with a personal history of recurrent exertional rhabdomyolysis found to have a heterozygous RYR1 c.13230G>C p.(Glu4410Asp) variant. She later tested negative via the gold-standard Caffein–Halothane Contracture Test (CHCT). A negative CHCT test with an in silico Rare Exome Variant Ensemble Learner (REVEL) score of 0.171 meets the ClinGen MHS Variant Curation Expert Panel (VCEP) criteria for reclassification of the variant to Likely Benign. Additionally, the high allele frequency isolated within the African American (AA) population suggests a benign, ancestry-specific polymorphism maintained within the AA population rather than a pathogenic MHS mutation. Therefore, reclassifying the variant to Likely Benign prevents unnecessary muscle biopsies and alterations to perioperative anesthetic management and reduces the need for family cascade testing, and reduces use of potentially suboptimal alternative anesthetic protocols.